2023 Form 5500 filing — Vivos Therapeutics, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241012152250NAL0013441635001) for Vivos Therapeutics, Inc. 401(K) Plan, reported by Vivos Therapeutics, Inc. under EIN 81-3224056 and plan number 001. It reports 187 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241012152250NAL0013441635001
Filing year
2023
Form type
3
Plan sponsor
Vivos Therapeutics, Inc.
EIN
81-3224056
Plan number
001
Location
Littleton, CO
Participants
187
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$1,573,528
Total liabilities (EOY)
$0
Net assets (EOY)
$1,573,528
Employer contributions
$144
Participant contributions
$393,702
Total income / additions
$645,136
Benefits paid
$278,135
Administrative expenses
$20,014
Total expenses
$298,149
Net increase / (decrease)
$346,987
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Empower Annuity Insurance Company FRECORDKEEPER$9,713$0
Vantage Financial Group, Inc.INVESTMENT ADVISOR$7,502not reported in the loaded dataset
Ascensus Holdings Inc Dba FutureplaCONTRACT ADMIN$1,564not reported in the loaded dataset

Related Form 5500 pages